Anterix (ATEX) EBITDA (2013 - 2026)

Anterix (ATEX) has reported EBITDA for 14 consecutive years, with $19.8 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $19.8 million, up 111.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.9 million (up 901.86% YoY), and the FY2026 annual result was $94.4 million, up 942.07% from the prior year.
• EBITDA was $19.8 million for Q1 2026 at Anterix, up from -$9.1 million in the prior quarter.
• Over five years, EBITDA peaked at $60.7 million in Q3 2025 and troughed at -$15.0 million in Q2 2024.
• Average EBITDA over 5 years is $2.6 million, with a median of -$2.8 million recorded in 2023.
• The widest YoY moves for EBITDA: up 625.7% in 2024, down 681.23% in 2024.
• Over 5 years, EBITDA stood at -$8.4 million in 2022, then jumped by 111.53% to $969000.0 in 2023, then surged by 625.7% to $7.0 million in 2024, then plunged by 228.85% to -$9.1 million in 2025, then surged by 318.91% to $19.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $19.8 million in Q1 2026, -$9.1 million in Q4 2025, and $60.7 million in Q3 2025.